These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6835173)

  • 1. Posttransfusion hepatitis in acute nonlymphocytic leukemia: lack of a beneficial influence.
    Markman M; Braine HG; Vaughan WP
    Med Pediatr Oncol; 1983; 11(1):37-8. PubMed ID: 6835173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransfusion hepatitis after induction chemotherapy in acute nonlymphoblastic leukemia: implications for long-term management and outcome.
    López-Jimenez J; Cancelas JA; García-Laraña J; Sastre JL; Cerveró C; Zamora C; Megido M; Hernández-Jodra M; Lasa E; Pérez-Oteyza J
    Transfusion; 1995 Apr; 35(4):313-8. PubMed ID: 7701549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
    Löwenberg B; Suciu S; Archimbaud E; Haak H; Stryckmans P; de Cataldo R; Dekker AW; Berneman ZN; Thyss A; van der Lelie J; Sonneveld P; Visani G; Fillet G; Hayat M; Hagemeijer A; Solbu G; Zittoun R
    J Clin Oncol; 1998 Mar; 16(3):872-81. PubMed ID: 9508168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-cycle timed-sequential chemotherapy for adult acute nonlymphocytic leukemia.
    Vaughan WP; Karp JE; Burke PJ
    Blood; 1984 Nov; 64(5):975-80. PubMed ID: 6487807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute nonlymphocytic leukemia in young and elderly patients.
    Beguin Y; Bury J; Fillet G; Lennes G
    Cancer; 1985 Dec; 56(11):2587-92. PubMed ID: 4052936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
    Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
    Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission-induction regimens in acute nonlymphocytic leukemia.
    Brennan DC; Lewis JP
    West J Med; 1980 Oct; 133(4):279-88. PubMed ID: 7347042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly.
    Kahn SB; Begg CB; Mazza JJ; Bennett JM; Bonner H; Glick JH
    J Clin Oncol; 1984 Aug; 2(8):865-70. PubMed ID: 6379120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia.
    Wong KK; Golomb HM; Rowley J; Baker AL; Testa J; Vardiman J
    Cancer Genet Cytogenet; 1982 Apr; 5(4):281-92. PubMed ID: 6807532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose cytosine arabinoside in the consolidation therapy of acute nonlymphocytic leukemia in remission.
    Takaku F; Urabe A; Mizoguchi H; Hoshino S; Toyama K; Tanaka K; Nomura T; Dan K; Fujioka S; Saito T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):55-7. PubMed ID: 3589698
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adults.
    Glucksberg H; Cheever MA; Farewell VT; Fefer A; Sale GE; Thomas ED
    Cancer; 1981 Sep; 48(5):1073-81. PubMed ID: 7023650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia.
    Peterson BA; Bloomfield CD; Theologides A; Kennedy BJ
    Cancer Treat Rep; 1981; 65 Suppl 4():29-33. PubMed ID: 6955011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocyte leukemia: a randomized collaborative study.
    Mandelli F; De Lipsis E; Grignani F; Martelli M; Liso V; Amadori S
    Med Pediatr Oncol; 1978; 4(3):231-40. PubMed ID: 277749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with daunorubicin, cytosine arabinoside and prednisolone (DAP) in acute nonlymphocytic leukemia.
    Kaku K; Nakashima K; Shinohara K; Hiroshige Y; Ishida Y; Fujii S; Yaga K; Matsumoto N; Miwa S
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):881-6. PubMed ID: 7331708
    [No Abstract]   [Full Text] [Related]  

  • 18. Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy.
    Duane SF; Peterson BA; Bloomfield CD; Michels SD; Hurd DD
    Med Pediatr Oncol; 1985; 13(4):207-13. PubMed ID: 4010622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
    Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
    Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis in patients with acute nonlymphocytic leukemia.
    Wade JC; Gaffey M; Wiernik PH; Schimpff SC; Schiffer CA; Wesley M; Hoofnagle JH
    Am J Med; 1983 Sep; 75(3):413-22. PubMed ID: 6412546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.